Ceapro Osake

Ceapro EBITDA

Delisted

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Ceapro (CZO.V) 6.8.2026 päivämäärällä on −5,86 M CAD. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli 5,68 M CAD — muutos −203,17 % (matalampi).

EBITDA

−5,86 MCAD

YoY

−203,17%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Ceapro on 2026 −5,86 M CAD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Ceapro oli 2025 5,68 M CAD. Se laskee −203,17% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Ceapro Osakeanalyysi

Mitä Ceapro tekee? Ceapro Inc is an innovative biotechnology company based in Edmonton, Canada. The company was founded in 1997 and has since specialized in the development of natural, biological ingredients from plants. It is listed on the Toronto Stock Exchange and has become a key player in the field of natural-based medicine and cosmetics in recent years. Ceapro's business model is based on the research and production of active compounds from plant-based raw materials. The company employs gentle extraction methods that preserve the effectiveness of the ingredients and enable environmentally friendly production. Ceapro collaborates closely with research and industry to ensure the best possible effectiveness and applicability of its products. The company's products are divided into various segments tailored to the needs of customers. One important segment is medicine, where Ceapro focuses on the development of herbal remedies. The company has already developed some promising products in this area, which can be used, for example, for inflammation, pain, or diabetes. Another important segment of Ceapro is cosmetics, where the company researches and produces natural ingredients for skin and hair care. These products are known for their high effectiveness, tolerability, and environmental friendliness. One of the company's most famous products is Avenanthramide, an ingredient derived from oats that offers anti-aging and anti-inflammatory properties. Ceapro also places special emphasis on the development of digestive-aid ingredients that can be used in the food industry. The company relies on plant enzymes and compounds that help support and relieve the digestive system. The use of natural ingredients ensures high tolerability and usability. Over the course of its history, Ceapro Inc has already won numerous awards and prizes that confirm the high quality of its products and the company's innovative power. For example, the company has been repeatedly honored with the Alberta Venture Fast Growth 50 Award and also received the Environmental Stewardship Award from the Edmonton Chamber of Commerce. Ceapro is not only an innovative biotechnology company specializing in the research and production of plant-based ingredients but also an important player in the fields of medicine and cosmetics. The company employs gentle extraction methods and collaborates closely with research and industry to achieve the best possible effectiveness and applicability. The different products are divided into the segments of medicine, cosmetics, and food and are known for their high effectiveness, tolerability, and environmental friendliness. Ceapro on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Ceapro osakkeesta

Yhtiön Ceapro EBITDA (Tulos ennen korkoja, veroja ja poistoja) on −5,86 M CAD vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Ceapro muuttui arvosta 5,68 M CAD arvoon −5,86 M CAD, mikä edustaa −203,17 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Ceapro:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n CAD on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Ceapro historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Ceapro

Kaikki tunnusluvut — Ceapro